Published in Cancer Weekly, January 5th, 2010
"Patients with a histologically confirmed diagnosis of stage N0 papillary thyroid cancer but no previous oncologic treatment, no recurrent tumor, and no distant metastasis. Central neck dissection intended as curative treatment. Disease-free survival. Demographic, clinical, therapeutic, pathologic, and neck recurrence information was also collected. A total of 266 patients...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.